Current environment: bad debt still taking its toll
Article Abstract:
The downward trend observed in the 2001 and 2002, continues for healthcare industry in 2005. This is mainly due to increase in the number of self-pay and uninsured patients. The rise in the consumer healthcare costs, popularity in health savings accounts, the regulatory outlook, increased competition among specialty hospitals and traditional acute care providers, and the economic performance of the for-profit hospitals, are also discussed.
Publication Name: Standard & Poor's Industry Surveys: Health Care
Subject: Health care industry
ISSN: 0196-4666
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
Bad debt: finally on the mend?
Article Abstract:
The economic downtrend in 2001 and 2002 and corresponding effects on indebtedness of healthcare facilities in United States are discussed. The prospects for the industry in 2005 appear to be promising. The positive aspects of regulations pertaining to the industry are examined. Health savings accounts and specialty hospital issues are also mentioned.
Publication Name: Standard & Poor's Industry Surveys: Health Care
Subject: Health care industry
ISSN: 0196-4666
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
How to analyze a healthcare facility company
Article Abstract:
Methods to analyze a healthcare facility based on regulations governing it, management issues which influence revenue and earnings growth, company's competitive advantage, financial issues such as operating margins, revenues and labor, corporate governance, etc, are furnished.
Publication Name: Standard & Poor's Industry Surveys: Health Care
Subject: Health care industry
ISSN: 0196-4666
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Current environment. Industry trends
- Abstracts: Current environment: Medicare part D looms, ongoing fallout from Vioxx. GSK to post summaries of trial results online
- Abstracts: Current environment: Vioxx casts a beleaguered drug industry. Pfizer petitions FDA to reject Sandoz' filing for Omnitrop
- Abstracts: Key industry ratio and statistics. How the industry operates. Key industry ratios and statistics
- Abstracts: Industry trends. Generics take center state